TGFBR2 and polycystic ovary syndrome: Moreover, the expression of TGFBR2 was significantly diminished in PCOS group (HA and NA patients) when compared to control group (P = 0.002) (Supplementary Fig. S1C) but no significant change in SAMD7 alternation was observed (Supplementary Fig. S1D).